Odysseas Kostas D 4
4 · Armata Pharmaceuticals, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Kostas Odysseas D
Director
Transactions
- Award
Stock Options (Right to Buy)
2024-03-14+39,666→ 39,666 totalExercise: $3.38Exp: 2034-03-14→ Common Stock (39,666 underlying) - Award
Stock Options (Right to Buy)
2024-03-14+54,343→ 94,009 totalExercise: $3.38Exp: 2034-03-14→ Common Stock (54,343 underlying)
Footnotes (2)
- [F1]The Options shall vest upon the Company's 2024 annual shareholders meeting subject to the Non-Employee Director's continuous service through immediately prior to the convening of such meeting, with the date of grant being March 14, 2024.
- [F2]The Options shall vest (i) 50% on March 14, 2025 and (ii) 50% on March 14, 2026, in each case subject to continuous service through such vesting date.